Blacksmith Medicines Overview
- Year Founded
-
2017
- Status
-
Private
- Employees
-
11
- Latest Deal Type
-
Grant
- Latest Deal Amount
-
$3.3M
- Investors
-
7
Blacksmith Medicines General Information
Description
Developer of metalloenzyme-targeting medicines designed to treat immuno-oncology and inflammatory diseases. The company's platform combines metal-binding pharmacophores with computational modeling and structure-based drug design, enabling pharmaceutical researchers and clinicians to develop selective inhibitors with improved efficacy and safety profiles for patients with cancer and immune-related disorders.
Contact Information
Website
www.blacksmithmedicines.comCorporate Office
- 3033 Science Park Road
- Suite 270
- San Diego, CA 92121
- United States
Corporate Office
- 3033 Science Park Road
- Suite 270
- San Diego, CA 92121
- United States
Blacksmith Medicines Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 4. Grant | 21-Feb-2024 | $3.3M | Completed | Pre-Clinical Trials | ||
| 3. Merger/Acquisition | 02-Jan-2023 | Cancelled | Pre-Clinical Trials | |||
| 2. Seed Round | 15-Nov-2019 | $350K | $350K | Completed | Pre-Clinical Trials | |
| 1. University Spin-Out | 01-Jan-2017 | Completed | Pre-Clinical Trials |
Blacksmith Medicines Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Seed |
Blacksmith Medicines Comparisons
Industry
Financing
Details
Blacksmith Medicines Competitors (2)
One of Blacksmith Medicines’s 2 competitors is CytomX Therapeutics, a Formerly VC-backed company based in South San Francisco, CA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| CytomX Therapeutics | Formerly VC-backed | South San Francisco, CA | ||||
| Aclaris Therapeutics | Formerly VC-backed | Wayne, PA |
Blacksmith Medicines Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Blacksmith Medicines Patents
Blacksmith Medicines Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2025174868-A1 | Antibacterial compounds | Pending | 13-Feb-2024 | ||
| WO-2025174875-A1 | Antibacterial compounds | Pending | 13-Feb-2024 | ||
| EP-4568955-A1 | Antibacterial compounds | Pending | 10-Aug-2022 | ||
| EP-4568955-A4 | Antibacterial compounds | Pending | 10-Aug-2022 | ||
| US-20260049092-A1 | Antibacterial compounds | Pending | 10-Aug-2022 | C07D491/107 |
Blacksmith Medicines Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Blacksmith Medicines Investors (7)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| National Institute Of Allergy and Infectious Diseases | Government | |||
| Alexandria Venture Investments | Venture Capital | Minority | ||
| Evotec | Corporation | Minority | ||
| MagnaSci Ventures | Venture Capital | Minority | ||
| MP Healthcare Venture Management | Corporate Venture Capital | Minority |
Blacksmith Medicines Acquisitions (1)
Blacksmith Medicines’s most recent deal was a Merger/Acquisition with Forge Therapeutics. The deal was made on 02-Jan-2023.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Forge Therapeutics | 02-Jan-2023 | Merger/Acquisition | Drug Discovery |
Blacksmith Medicines FAQs
-
When was Blacksmith Medicines founded?
Blacksmith Medicines was founded in 2017.
-
Where is Blacksmith Medicines headquartered?
Blacksmith Medicines is headquartered in San Diego, CA.
-
What is the size of Blacksmith Medicines?
Blacksmith Medicines has 11 total employees.
-
What industry is Blacksmith Medicines in?
Blacksmith Medicines’s primary industry is Biotechnology.
-
Is Blacksmith Medicines a private or public company?
Blacksmith Medicines is a Private company.
-
What is Blacksmith Medicines’s current revenue?
The current revenue for Blacksmith Medicines is .
-
How much funding has Blacksmith Medicines raised over time?
Blacksmith Medicines has raised $350K.
-
Who are Blacksmith Medicines’s investors?
National Institute Of Allergy and Infectious Diseases, Alexandria Venture Investments, Evotec, MagnaSci Ventures, and MP Healthcare Venture Management are 5 of 7 investors who have invested in Blacksmith Medicines.
-
Who are Blacksmith Medicines’s competitors?
CytomX Therapeutics and Aclaris Therapeutics are competitors of Blacksmith Medicines.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
